|
FOXK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19744231092045E-14 |
| Normal-vs-Stage2 |
1.322530E-03 |
| Normal-vs-Stage3 |
5.557700E-02 |
| Normal-vs-Stage4 |
6.309600E-02 |
| Stage1-vs-Stage2 |
6.335000E-01 |
| Stage1-vs-Stage3 |
3.004800E-03 |
| Stage1-vs-Stage4 |
9.375600E-01 |
| Stage2-vs-Stage3 |
4.956500E-02 |
| Stage2-vs-Stage4 |
8.351800E-01 |
| Stage3-vs-Stage4 |
2.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33226762955019E-15 |
| Normal-vs-AfricanAmerican |
1.11990000051243E-07 |
| Normal-vs-Asian |
4.715800E-01 |
| Caucasian-vs-AfricanAmerican |
6.874600E-01 |
| Caucasian-vs-Asian |
2.956000E-01 |
| AfricanAmerican-vs-Asian |
4.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
2.34899999451699E-08 |
| Male-vs-Female |
4.895800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.39139999999482E-06 |
| Normal-vs-Extreme_Weight |
5.0185999800334E-10 |
| Normal-vs-Obese |
3.82059994752382E-09 |
| Normal-vs-Extreme_Obese |
7.977100E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.903000E-01 |
| Normal_Weight-vs-Obese |
4.365400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.051000E-01 |
| Extreme_Weight-vs-Obese |
8.623800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.799400E-01 |
| Obese-vs-Extreme_Obese |
6.908800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.182800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.63868918434673E-12 |
| Normal-vs-Age(61-80Yrs) |
8.476774837618E-12 |
| Normal-vs-Age(81-100Yrs) |
2.092000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.801000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.848350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.074200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.215000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.942200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.934000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.641610E-02 |
| Normal-VS-KIRP CIMP |
2.824300E-02 |
| Normal-VS-Unclassified PRCC |
5.24639999999188E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.3988810110277E-14 |
| Type1 PRCC-VS-KIRP CIMP |
1.631580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.210580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.703800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.68819999999803E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
5.783400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.394700E-04 |
| Normal-vs-N1 |
5.164600E-03 |
| Normal-vs-N2 |
2.323400E-01 |
| N0-vs-N1 |
8.956200E-01 |
| N0-vs-N2 |
4.144600E-01 |
| N1-vs-N2 |
4.302200E-01 |
|
|
